Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol or olanzapine added before midazolam for severe agitation sedation
ACTRN12607000591459Phase 4Completed
- Sponsor
- Austin Hospital
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of droperidol, olanzapine and midazolam in agitation (3 arms), sponsored by Austin Hospital. Primary endpoint: Time to adequate sedation. Started Aug 2009; status: completed.
02
Drugs
droperidololanzapinemidazolam
03
Conditions
agitation
Beyond the preview
Go deeper on ACTRN12607000591459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000591459.